Publications en collaboration avec des chercheurs de Hospital General Universitario Gregorio Marañón (99)

2024

  1. Accelerated Cortical Thinning in Schizophrenia Is Associated With Rare and Common Predisposing Variation to Schizophrenia and Neurodevelopmental Disorders

    Biological Psychiatry, Vol. 96, Núm. 5, pp. 376-389

  2. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

  3. Child psychiatry cannot afford not to properly study differences by sex

    European Child and Adolescent Psychiatry

  4. Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I

    Journal of Psychopharmacology, Vol. 38, Núm. 4, pp. 311-317

  5. Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II

    Journal of Psychopharmacology, Vol. 38, Núm. 4, pp. 318-323

  6. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

  7. Psychopharmacology in children and adolescents: unmet needs and opportunities

    The Lancet Psychiatry, Vol. 11, Núm. 2, pp. 143-154

  8. Running in the FAMILY: understanding and predicting the intergenerational transmission of mental illness

    European Child and Adolescent Psychiatry

  9. Spanish experts consensus on emergency psychiatric care in hospital emergency departments

    BMC Psychiatry, Vol. 24, Núm. 1

  10. Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data

    Wellcome Open Research, Vol. 9

2023

  1. Addressing the complexity of child psychiatry practice in the current landscape

    European Child and Adolescent Psychiatry

  2. Common practical questions – and answers – at the British Association for Psychopharmacology child and adolescent psychopharmacology course

    Journal of Psychopharmacology, Vol. 37, Núm. 2, pp. 119-134

  3. Correction to: Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group (Pediatric Research, (2022), 91, 5, (1069-1077), 10.1038/s41390-021-01587-3)

    Pediatric Research

  4. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  5. Digital mental health: challenges and next steps

    BMJ mental health, Vol. 26, Núm. 1

  6. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis

    British Journal of Psychiatry, Vol. 31, Núm. 2

  7. New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosis

    BMJ mental health, Vol. 26, Núm. 1

  8. Oxytocin Exposure in Labor and its Relationship with Cognitive Impairment and the Genetic Architecture of Autism

    Journal of Autism and Developmental Disorders, Vol. 53, Núm. 1, pp. 66-79

  9. Strategies to facilitate adolescent access to medicines: Improving regulatory guidance

    Clinical Trials, Vol. 20, Núm. 1, pp. 13-21

  10. The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications

    Neuroscience and Biobehavioral Reviews, Vol. 149